WebMar 1, 2024 · The standard treatment for postoperative high-risk locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) is chemoradiotherapy … WebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important.
Cisplatin Uses, Side Effects & Warnings - Drugs.com
WebThe quality of radiation therapy has been shown to significantly influence the outcomes for head and neck squamous cell carcinoma (HNSCC) patients. The results of dosimetric studies suggest that intensity-modulated proton therapy (IMPT) could be of added value for HNSCC by being more effective than intensity-modulated (photon) radiation therapy ... WebMay 18, 2024 · The use of chemotherapy in combination with ADT for castration-sensitive disease is discussed separately, as are the benefits of treatments for CRPC targeting the androgen pathway, immunotherapy, poly (ADP-ribose) polymerase (PARP) inhibitors for men with homologous recombination repair deficiency, and experimental approaches. culvers work uniform
Optimal regimen of cisplatin in squamous cell carcinoma of head and
WebApr 12, 2024 · As a sixth-line treatment, a 72-year-old man with Hashimoto's disease and advanced lung squamous cell carcinoma was given cisplatin plus gemcitabine with necitumumab, which is a human monoclonal antibody that interacts with EGFR. Tumor decrease was detected, but on day 8 of the second cycle, asymptomatic grade 4 … WebFeb 16, 2024 · Warnings. Cisplatin can affect your nervous system, increase your risk of bleeding or infection, or harm your kidneys.. Call your doctor if you have a fever, mouth … WebMay 3, 2024 · Cisplatin 100 mg/m 2 IV on day 1 every 3wk for six cycles plus 5-FU 1000 mg/m 2 /day by continuous IV infusion on days 1-4 every 3wk for six cycles plus cetuximab 400 mg/m 2 IV loading dose on... culvers wisconsin burger